Cargando…

Peroxisome proliferator‐activated receptor gamma‐ligand‐binding domain mutations associated with familial partial lipodystrophy type 3 disrupt human trophoblast fusion and fibroblast migration

The transcription factor peroxisome proliferator‐activated receptor gamma (PPARG) is essential for placental development, and alterations in its expression and/or activity are associated with human placental pathologies such as pre‐eclampsia or IUGR. However, the molecular regulation of PPARG in cyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shoaito, Hussein, Chauveau, Sabine, Gosseaume, Camille, Bourguet, William, Vigouroux, Corinne, Vatier, Camille, Pienkowski, Catherine, Fournier, Thierry, Degrelle, Séverine A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339198/ https://www.ncbi.nlm.nih.gov/pubmed/32519441 http://dx.doi.org/10.1111/jcmm.15401

Ejemplares similares

Metreleptin therapy in LMNA-linked lipodystrophies
por: Vatier, Camille, et al.
Publicado: (2015)

The Role of Peroxisome Proliferator–Activated Receptor Gamma ([Formula: see text]) in Mono(2-ethylhexyl) Phthalate (MEHP)-Mediated Cytotrophoblast Differentiation
por: Shoaito, Hussein, et al.
Publicado: (2019)

New Transcriptional Reporters to Quantify and Monitor PPARγ Activity
por: Degrelle, Séverine A., et al.
Publicado: (2017)

Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy
por: Jéru, Isabelle, et al.
Publicado: (2019)

Molecular and Cellular Bases of Lipodystrophy Syndromes
por: Zammouri, Jamila, et al.
Publicado: (2022)

IFITM1 inhibits trophoblast invasion and is induced in placentas associated with IFN-mediated pregnancy diseases
por: Degrelle, Séverine A., et al.
Publicado: (2023)

European lipodystrophy registry: background and structure
por: von Schnurbein, Julia, et al.
Publicado: (2020)

Looking at New Unexpected Disease Targets in LMNA-Linked Lipodystrophies in the Light of Complex Cardiovascular Phenotypes: Implications for Clinical Practice
por: Mosbah, Héléna, et al.
Publicado: (2020)

SUN-037 Diagnosis Challenge in Type 4 Familial Partial Lipodystrophic Syndrome
por: Vantyghem, Marie-Christine, et al.
Publicado: (2019)

Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome
por: Donadille, Bruno, et al.
Publicado: (2013)

Case Report: A New Peroxisome Proliferator-Activated Receptor Gamma Mutation Causes Familial Partial Lipodystrophy Type 3 in a Chinese Patient
por: Chen, Xi, et al.
Publicado: (2022)

Annexin-A5 organized in 2D-network at the plasmalemma eases human trophoblast fusion
por: Degrelle, Severine A., et al.
Publicado: (2017)

Antiretroviral-Related Adipocyte Dysfunction and Lipodystrophy in HIV-Infected Patients: Alteration of the PPARγ-Dependent Pathways
por: Caron, Martine, et al.
Publicado: (2009)

Benzo(a)pyrene and Cerium Dioxide Nanoparticles in Co-Exposure Impair Human Trophoblast Cell Stress Signaling
por: Deval, Gaëlle, et al.
Publicado: (2023)

Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real‐life experience from a national reference network
por: Mosbah, Héléna, et al.
Publicado: (2022)

Primary Bovine Extra-Embryonic Cultured Cells: A New Resource for the Study of In Vivo Peri-Implanting Phenotypes and Mesoderm Formation
por: Hue, Isabelle, et al.
Publicado: (2015)

Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes
por: Vatier, Camille, et al.
Publicado: (2019)

Peroxisomal proliferator activated receptor-γ deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)
por: Francis, Gordon A, et al.
Publicado: (2006)

Type 2 Diabetes With Partial Lipodystrophy of the Limbs: A new lipodystrophy phenotype
por: Strickland, Leah R., et al.
Publicado: (2013)

Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions
por: Peng, Lin, et al.
Publicado: (2021)

Lamin A tail modification by SUMO1 is disrupted by familial partial lipodystrophy–causing mutations
por: Simon, Dan N., et al.
Publicado: (2013)

Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC
por: Rubio-Cabezas, Oscar, et al.
Publicado: (2009)

The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline
por: Brown, Rebecca J., et al.
Publicado: (2016)

Familial Partial Lipodystrophy (FPLD): Recent Insights
por: Bagias, Christos, et al.
Publicado: (2020)

Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives
por: Vigouroux, Corinne, et al.
Publicado: (2018)

Comparative Study of PPARγ Targets in Human Extravillous and Villous Cytotrophoblasts
por: Liu, Fulin, et al.
Publicado: (2020)

Age and Sex-Related Changes in Human First-Trimester Placenta Transcriptome and Insights into Adaptative Responses to Increased Oxygen
por: Liu, Fulin, et al.
Publicado: (2021)

Transcriptome analysis of primary bovine extra-embryonic cultured cells
por: Degrelle, Séverine A.
Publicado: (2015)

The acromegaly lipodystrophy
por: Freda, Pamela U.
Publicado: (2022)

Evaluation of epicardial adipose tissue in familial partial lipodystrophy
por: Godoy-Matos, Amélio Fernando, et al.
Publicado: (2015)

Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges
por: Chiquette, Elaine, et al.
Publicado: (2017)

SUN-556 Cardiac Phenotype in Familial Partial Lipodystrophy
por: Eldin, Abdelwahab Jalal, et al.
Publicado: (2020)

Interferon-gamma alters the phagocytic activity of the mouse trophoblast
por: Albieri, Andréa, et al.
Publicado: (2005)

C1431T Variant of PPARγ Is Associated with Preeclampsia in Pregnant Women
por: Liu, Fulin, et al.
Publicado: (2021)

Insulin lipodystrophy and lipohypertrophy
por: Mokta, Jatinder K., et al.
Publicado: (2013)

Recurrent stroke as a presenting feature of acquired partial lipodystrophy
por: Prasad, Namburi R., et al.
Publicado: (2012)

Adult-Onset Acquired Partial Lipodystrophy Accompanied by Rheumatoid Arthritis
por: Muto, Yusuke, et al.
Publicado: (2015)

Bleomycin Containing Chemotherapeutic Regimen Induced Acquired Partial Lipodystrophy
por: Tandon, Vishal R, et al.
Publicado: (2016)

Partial Lipodystrophy and LMNA p.R545H Variant
por: Magno, Silvia, et al.
Publicado: (2021)

Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain
por: Fernández-Pombo, Antía, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5t4qivkr3knmd1prq22up9k547